A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient s current antipsychotic medication(s)

Impact of Isoflurane and Desflurane on Recovery Time and Postoperative Nausea in Patients Undergoing Laparoscopic Cholecystectomy

The Chronic kidney disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE)

Investigation of clinical efficacy and safety of herbal drug in patients with non-alcoholic fatty liver disease (NAFLD)

Effectiveness of combining letrozole with misoprostol compared to misoprostol alone in the medical management of missed miscarriage - A randomized control trial

Efficacy of Hydroxyurea and Thalidomide in the Management of Beta Thalassemia

Development of a mobile-based mindfulness intervention and study of its effectiveness in improving maternal psychological wellbeing

The effect of sit-to-stand training combined with core strengthening on the balance and gait of the patient affected with stroke - a Randomised Controlled Trial

A Randomized Clinical Trial Comparing the Efficacy of Preoperative vs. Postoperative Antibiotic Regimens in Single Straightforward Dental Implant Procedures

Evaluation of One-Stitch Versus Two-Stitch Laparoscopic Burch Colposuspension for Stress Urinary Incontinence (SUI): A Randomized Clinical Trial